Psyence Biomedical Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2022
12/31/2021
Revenue
0
0
0
Revenue Growth (YoY)
--
--
--
Cost of Revenue
--
--
--
Gross Profit
--
--
--
Selling, General & Admin
1
1
0
Research & Development
--
--
--
Operating Expenses
1
1
0
Other Non Operating Income (Expenses)
--
--
-1
Pretax Income
2
8
8
Income Tax Expense
--
--
--
Net Income
2
8
8
Net Income Growth
--
0%
--
Shares Outstanding (Diluted)
0
32.68
32.68
Shares Change (YoY)
--
0%
--
EPS (Diluted)
5,157.89
0.25
0.25
EPS Growth
--
0%
--
Free Cash Flow
0
0
0
Free Cash Flow Per Share
--
--
--
Gross Margin
--
--
--
Operating Margin
0%
0%
0%
Profit Margin
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
EBITDA
--
--
--
EBITDA Margin
--
--
--
D&A For EBITDA
--
--
--
EBIT
-1
-1
0
EBIT Margin
0%
0%
0%
Effective Tax Rate
--
--
--
Follow-Up Questions
What are Psyence Biomedical Ltd's key financial statements?
According to the latest financial statement (Form-10K), Psyence Biomedical Ltd has a total asset of $258, Net profit of $8
What are the key financial ratios for PBM?
Psyence Biomedical Ltd's Current ratio is 18.42, has a Net margin is 0, sales per share of $0.
How is Psyence Biomedical Ltd's revenue broken down by segment or geography?
Psyence Biomedical Ltd largest revenue segment is Cloud Platform Products, at a revenue of 40,877,256 in the most earnings release.For geography, China is the primary market for Psyence Biomedical Ltd, at a revenue of 70,314,315.
Is Psyence Biomedical Ltd profitable?
yes, according to the latest financial statements, Psyence Biomedical Ltd has a net profit of $8
Does Psyence Biomedical Ltd have any liabilities?
yes, Psyence Biomedical Ltd has liability of 14
How many outstanding shares for Psyence Biomedical Ltd?
Psyence Biomedical Ltd has a total outstanding shares of 32.7